# RELEVARE PHARMACEUTICALS INC — Form D

RELEVARE PHARMACEUTICALS INC of BRISBANE QUEENLAND, C3, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-02. Industry: Biotechnology.

## Offering

- Filed: 2011-03-02
- Form: D
- Accession: 0001455487-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Date of first sale: 2010-11-16
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-156115

## Issuer

- Name: RELEVARE PHARMACEUTICALS INC
- CIK: 0001455487
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: LEVEL 5 CENTRAL PLAZA 2, BRISBANE QUEENLAND, C3, 4001
- Phone: 61730096850

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Matthew Morgan | Director | PORTLAND, OR |
| Mark Blumling | Director | Brooklyn, NY |
| Mark Blumling | Executive Officer | Brooklyn, NY |
| ANDREW HARPUR MICHELL | Director | BRISBANE, QLD, C3 |
| Andy Gearing | Director | San Francisco, CA |
| Ross Macdonald | Director | San Francisco, CA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2012-06-15](https://search.stillhousedata.com/formd/0001455487-12-000005) | D | $750K | $750K |
| [2010-04-20](https://search.stillhousedata.com/formd/0001455487-10-000003) | D | $5.3M | $5.3M |
| [2010-04-20](https://search.stillhousedata.com/formd/0001455487-10-000004) | D | $3.2M | $3.0M |

## More

- [CIK 1455487 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1455487&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001455487-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.